stoxline Quote Chart Rank Option Currency Glossary
  
MedAvail Holdings, Inc. (MDVL)
1.8  -1.37 (-43.22%)    02-12 16:00
Open: 2.51
High: 2.54
Volume: 236,126
  
Pre. Close: 3.17
Low: 1.7362
Market Cap: 3(M)
Technical analysis
2024-05-31 4:54:11 PM
Short term     
Mid term     
Targets 6-month :  1.22 1-year :  1.98
Resists First :  1.05 Second :  1.7
Pivot price 1
Supports First :  0 Second :  0
MAs MA(5) :  0.27 MA(20) :  1.1
MA(100) :  2.38 MA(250) :  6.77
MACD MACD :  -0.4 Signal :  -0.3
%K %D K(14,3) :  0 D(3) :  0
RSI RSI(14): 14.4
52-week High :  20.88 Low :  0
Price, MAs and Bollinger Bands

Price has closed below its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is BEARISH in short-term; and BEARISH in mid-long term.
[ MDVL ] has closed above bottom band by 8.5%. Bollinger Bands are 26.2% wider than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Stock Price Prediction
If tomorrow: Open lower Open higher
High: 0 - 0 0 - 0
Low: 0 - 0 0 - 0
Close: 0 - 0 0 - 0
Company Description

MedAvail Holdings, Inc., a technology-enabled retail pharmacy technology and services company, develops and commercializes self-service pharmacy, mobile application, kiosk, and drive-thru solutions in the United States and Canada. It operates in two segments, Retail Pharmacy Services and Pharmacy Technology. The company's MedCenter enables on-site pharmacy in medical clinics, retail store locations, employer sites with and without onsite clinics, and other location where onsite prescription dispensing is desired, as well as establishes an audio-visual connection to a live pharmacist enabling prescription drug dispensing to occur directly to a patient with real-time supervision by a pharmacist. It also owns and operates SpotRx, a retail pharmacy platform. As of December 31, 2021, the company had 81 MedCenter kiosks. MedAvail Holdings, Inc. is headquartered in Mississauga, Canada.

Headline News

Fri, 09 Feb 2024
MedAvail Holdings Faces Nasdaq Delisting After Bankruptcy - TipRanks.com - TipRanks

Sat, 03 Feb 2024
MedAvail Holdings Files for Chapter 7 Bankruptcy - TipRanks.com - TipRanks

Sat, 03 Feb 2024
MedAvail Holdings Announces Major Board and Executive Shake-Up - TipRanks.com - TipRanks

Thu, 17 Aug 2023
Slammed 31% MedAvail Holdings, Inc. (NASDAQ:MDVL) Screens Well Here But There Might Be A Catch - Simply Wall St

Fri, 05 May 2023
MDVL: The Bottom of the Barrel: The Worst Drug Store Stock for Investors - StockNews.com

Mon, 12 Dec 2022
Most Oversold Stocks In Consumer Staples Sector: Herbalife, United Natural Foods And More - Herbalife (NY - Benzinga

Financial Analysis
Price to Book Value:
P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.
Outperform
Price to Earnings:
PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).
Underperform
Discounted cash flow:
DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.
Neutral
Return on Assets:
ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.
Underperform
Return on Equity:
ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.
Underperform
Debt to Equity:
evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.
Neutral
Stock Basics & Statistics
Exchange:
NASDAQ
Sector:
Healthcare
Industry:
Medical - Pharmaceuticals
Shares Out 0 (M)
Shares Float 2 (M)
Held by Insiders 380040 (%)
Held by Institutions 0.3 (%)
Shares Short 32 (K)
Shares Short P.Month 0 (K)
Stock Financials
EPS -4.052e+007
EPS Est Next Qtrly 0
EPS Est This Year 0
EPS Est Next Year 0
Book Value (p.s.) 0
Profit Margin -106.2 %
Operating Margin -1 %
Return on Assets (ttm) 99.7 %
Return on Equity (ttm) -68.2 %
Qtrly Rev. Growth 4.333e+007 %
Gross Profit (p.s.) 1.33
Sales Per Share 26.91
EBITDA (p.s.) -25.17
Qtrly Earnings Growth -35.6 %
Operating Cash Flow 0 (M)
Levered Free Cash Flow -32 (M)
Stock Valuations
PE Ratio -0.01
PEG Ratio 0
Price to Book value 0
Price to Sales 0
Price to Cash Flow -0.01
Stock Dividends
Dividend 0
Forward Dividend 10290
Dividend Yield 0%
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.

StockChart iOS

StoxlineLite iOS

StoxlineLite iOS

OptionCalc iOS

StockChart Android

StoxlineLite Android

StoxlinePro Android

OptionCalc Android